Stem cell services provider WideCells (WDC) hopes to take advantage of 3m cord blood samples held in storage in 500 facilities globally. Cord blood remains in the placenta and contains stem cells, which can be used to treat genetic disorders.

WideCells currently has agreements with global facilities that store approximately 1,000 blood cord samples worldwide.

The company uses these deals to offer stem cell insurance when people want their blood cord stem cells stored. The company expects to expand its deals to cover another 5,000 to 6,000 samples in the next three years.